Remimazolam

Byfavo 50 mg, poeder voor concentraat voor oplossing voor injectie/infusie

Poeder voor concentraat voor oplossing voor injectie / infusieNetherlandsAuthorisedAuthorised 26 Mar 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ByfavoEuropean UnionAuthorised

ByfavoBrazil · Cristália Produtos Químicos Farmacêuticos Ltda.Same brand
Byfavo 20 MG Polvo Para Solucion InyectableSpain · 27,2 mg · polvo para solución inyectable · Paion Pharma GmbhSame brand
ByfavoEuropean Union · Paion Pharma GmbHSame brand
ByfavoCroatiaSame brand
ByfavoItaly · Polvere per concentrato per soluzione iniettabile/infusione · Paion Pharma GMBHSame brand
Byfavo Powder for Solution for Injection 20MGSingapore · 20 mg · injection, powder, lyophilized, for solution · Hyphens Pharma Pte. LTD.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Remimazolam

Byfavo 50 mg, poeder voor concentraat voor oplossing voor injectie/infusie

Poeder voor concentraat voor oplossing voor injectie / infusieNetherlandsAuthorisedAuthorised 26 Mar 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ByfavoEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ByfavoUnited States · 20MG BASE/VIAL · powder · Acacia

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Remimazolam
Dosage form: Poeder voor concentraat voor oplossing voor injectie / infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 26 Mar 2021
Registration: EU/1/20/1505
Marketing authorisation holder: Paion Pharma GmbH
ATC code: N05CD14
Group: Nervous system
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/005246
EU number: EU/1/20/1505